Germany Limits Use of Oxford-AstraZeneca Vaccine Because of Fears of Blood Clots

Federal health officials restrict recipients to 60 years old and older after 31 cases of blood clots were reported, including nine deaths... Read more

Bron:

Economy - Voice of America